INVESTOR AND MEDIA CONTACT:Cellceutix CorporationLeo Ehrlichinfo@cellceutix.com
TheStreet's Adam Feuerstein answers reader questions about biotech stocks.
TheStreet's Adam Feuerstein answers readers' questions about biotech stocks.
CEOs of troubled companies tend to launch public tirades against the 'evil' shorts. The rants are often a smokescreen meant to divert investors' attention from problems.